Human CellExp Cystatin C, Human recombinant protein
Human Recombinant Cystatin C
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P01036 |
|---|---|
| Calculated MW | 12-13 kDa |
| Gene ID | 1472 |
|---|---|
| Gene Symbol | CST4 |
| Other Names | Cystatin-3, Gamma-trace neuroendocrine basic polypeptide, Post-gamma-globulin |
| Gene Source | Human |
| Source | Human 293 cells |
| Assay&Purity | SDS-PAGE; ≥95% |
| Assay2&Purity2 | HPLC; |
| Recombinant | Yes |
| Results | Typically 0.3 to 1.5 µM IC50. |
| Application Notes | Reconstitute in sterile PBS. |
| Format | Lyophilized protein |
| Storage | -20°C; Lyophilized in PBS |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Xeno-free Cystatin C HuXp (Cys-C) is expressed in human 293 cells as a monomer with an apparent molecular mass of 12 to 13 kDa. Native Cys-C in human urine is found in two different forms: one with pI 9.2 and the other with pI 7.8 by elimination of small basic peptides or amino acids from the N-terminal end of protein. Cystatin C has been studied for its role in predicting new onset or deteriorating cardiovascular disease. This cytokine is produced in a serum-free, chemically defined media.
References
Bobek L.A.,et al.Biochem. J. 278:627-635(1991).
Saitoh E.,et al.Agents Actions 38:340-348(1992).
Dickinson D.P.,et al.Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
Deloukas P.,et al.Nature 414:865-871(2001).
Hawke D.H.,et al.Biochem. Biophys. Res. Commun. 145:1248-1253(1987).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.





Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.

